MNDIX
Price
$31.77
Change
-$0.00 (-0.00%)
Updated
Aug 5 closing price
Net Assets
2.06B
VEXRX
Price
$106.29
Change
-$0.06 (-0.06%)
Updated
Aug 5 closing price
Net Assets
20.12B
Interact to see
Advertisement

MNDIX vs VEXRX

Header iconMNDIX vs VEXRX Comparison
Open Charts MNDIX vs VEXRXBanner chart's image
MFS New Discovery I
Price$31.77
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets2.06B
Vanguard Explorer Adm
Price$106.29
Change-$0.06 (-0.06%)
VolumeN/A
Net Assets20.12B
MNDIX vs VEXRX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
MNDIX vs. VEXRX commentary
Aug 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MNDIX is a Buy and VEXRX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VEXRX has more cash in the bank: 20.1B vs. MNDIX (2.06B). VEXRX pays higher dividends than MNDIX: VEXRX (0.52) vs MNDIX (0.00). MNDIX was incepted earlier than VEXRX: MNDIX (29 years) vs VEXRX (24 years). MNDIX (1.04) is less costly to investors than VEXRX (0.33). MNDIX is a more actively managed with annual turnover of: 56.00 vs. VEXRX (35.00). MNDIX has a lower initial minimum investment than VEXRX: MNDIX (0) vs VEXRX (50000). MNDIX annual gain was more profitable for investors over the last year : 12.62 vs. VEXRX (3.17). VEXRX return over 5 years is better than : 4.04 vs. MNDIX (-12.86).
MNDIXVEXRXMNDIX / VEXRX
Total Expense Ratio1.030.33312%
Annual Report Gross Expense Ratio1.040.33315%
Fund Existence29 years24 years-
Gain YTD4.404-0.468-941%
Front LoadN/AN/A-
Min. Initial Investment050000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.06B20.1B10%
Annual Yield % from dividends0.000.52-
Returns for 1 year12.623.17398%
Returns for 3 years15.198.28183%
Returns for 5 years-12.864.04-318%
Returns for 10 years17.9719.4992%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FIVCX35.650.06
+0.17%
Macquarie Opportunity C
WELNX10.28N/A
N/A
William Blair Emerging Mkts Ldrs N
LHCQX18.15N/A
N/A
Lord Abbett Health Care R3
FSSLX11.96N/A
N/A
Fidelity Series Small Cap Core
FDEIX27.80N/A
N/A
Fidelity Advisor Capital Development I